Key Highlights
- Midi Health closes a $25M Series A funding round led by GV (Google Ventures). Total funding to date reaches $40M.
- Since its official launch last year, Midi Health has assisted tens of thousands of patients and is set to expand to all 50 states by January 2024.
- The new capital will be utilized to expand operations, launch partnerships with major hospital systems, and collaborate with U.S. employers.
- Midi Health recently partnered with fertility benefits leader, Progyny, and has agreements with Stanford University, ServiceNow, and Lifepoint Health.
- Every day, 6,000 U.S. women enter menopause, with symptoms severely impacting their quality of life and career growth.
- Joanna Strober, CEO & Founder of Midi Health, emphasizes the company’s focus on addressing the unique needs of women during menopause, ensuring they are not underserved.
- Midi Health offers a comprehensive care plan for patients, combining hormonal and non-hormonal medications, coaching, supplements, and integrative therapy recommendations.
Source: PR Newswire
Notable Quotes
- “Midi’s world-class executive and advisory team has decades of clinical and healthcare expertise and a vision for personalized, affordable, and accessible midlife care.” – Frederique Dame, General Partner at GV
- “It’s clear that menopausal symptoms can derail women’s lives… Midi provides an insurance-covered solution that focuses on women’s unique needs.” – Joanna Strober, CEO & Founder of Midi Health
SoH's Take
Midi Health’s recent funding round signifies a pivotal moment in women’s healthcare. By focusing on the unique challenges faced by women during midlife hormonal transitions, Midi Health is addressing a significant gap in the healthcare system. The company’s commitment to providing personalized, holistic care plans, combined with its partnerships and expansion plans, positions it as a leader in the field. With the backing of GV and other notable investors, Midi Health is poised to make a lasting impact on women’s health, ensuring they receive the care they deserve during this critical life stage.
